Form 8-K - Current report:
SEC Accession No. 0001437749-22-015226
Filing Date
2022-06-17
Accepted
2022-06-17 09:14:42
Documents
14
Period of Report
2022-06-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20220615_8k.htm   iXBRL 8-K 37098
2 EXHIBIT 16.1 ex_387346.htm EX-16.1 3440
  Complete submission text file 0001437749-22-015226.txt   175109

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kmph-20220614.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20220614_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20220614_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20220614_pre.xml EX-101.PRE 11688
8 EXTRACTED XBRL INSTANCE DOCUMENT kmph20220615_8k_htm.xml XML 2593
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 221022546
SIC: 2834 Pharmaceutical Preparations